Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-003686
Filing Date
2023-01-06
Accepted
2023-01-06 17:30:03
Documents
14
Period of Report
2022-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d389338d8ka.htm   iXBRL 8-K/A 30809
2 EX-99.1 d389338dex991.htm EX-99.1 190616
6 GRAPHIC g389338g0106164137256.jpg GRAPHIC 2610
  Complete submission text file 0001193125-23-003686.txt   379749

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20221230.xsd EX-101.SCH 2870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20221230_lab.xml EX-101.LAB 18700
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20221230_pre.xml EX-101.PRE 11708
8 EXTRACTED XBRL INSTANCE DOCUMENT d389338d8ka_htm.xml XML 4751
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-00100 | Film No.: 23516050
SIC: 2834 Pharmaceutical Preparations